Individualizing Care in Migraine: From Prevention to Acute ManagementPremiere Date: Friday, July 26, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
|David W. Dodick, MD
Department of Neurology
This video is a replay of a plenary session from the 11th Annual Chair Summit Master Class for Neuroscience Professional Development held in Ft. Lauderdale, FL on February 7-9, 2019.
At the end of this CE activity, participants should be able to:
- Incorporate evidence-based tools and strategies into routine practice to improve the differential diagnosis of migraine.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify evidence-based tools and strategies that can be incorporated into routine practice to improve the differential diagnosis of migraine.
This activity is supported by an educational grant from Teva Pharmaceuticals.
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other non-physician healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hours.
Note to Nurse Practitioners: Nurses can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hours (0.10 CEUs). Universal Activity Number: Enduring: 0376-0000-19-034-H01-P
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Dodick reports that he is a consultant for Alder Pharmaceuticals, Inc.; Allergan; Amgen Inc.; Autonomic Technologies Inc.; Biohaven Pharmaceuticals; Dr. Reddy's Laboratories, Inc.; electroCore, LLC; Eli Lilly and Company; eNeura Inc.; Impel NeuroPharma, Inc.; Ipsen Biopharmaceuticals, Inc.; Neurolief Ltd.; Novartis Pharmaceuticals Corporation; Satsuma Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Theranica Bio-Electronics LTD; W.L. Gore & Associates, Inc.; and Zosano Pharma Corporation. He receives equity from Aural Analytics; EPIEN Medical, Inc.; Healing; Mobile Health Management Services, Inc.; Nocira; Ontologics; and Theranica Bio-Electronics LTD. He holds Patent 17189376.1-1466: vTitle: Botulinum Toxin Dosage Regimen for Chronic Migraine Prophylaxis. He receives professional society fees or reimbursement for travel from the American Academy of Neurology; American Brain Foundation; American Headache Society; American Migraine Foundation; and International Headache Society.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).